Sistemic is offering a range of miRNA analytical services that are designed to provide reliable and cost-effective characterisation and QC tools that are applicable to all cell systems.
Dr Vincent O'Brien, chief scientific officer, and Dr Verna McErlane, international director of commercial operations, presented data supporting the utility of miRNA in the provision of cell characterisation and QC methods at the recent Stem Cells Europe conference in Edinburgh.
O'Brien presented a poster entitled 'A novel microRNA-based stem cell characterisation and monitoring tool', while McErlane joined Marilyn Robertson of the Scottish Stem Cell Network (SSCN), Aidan Courtney of Roslin Cells, Dr David Hay of Fibromed and Michael Leek of Immunosolv at the SSCN panel showcase, entitled 'Progress to Therapy and Market'.
Sistemic offers a variety of miRNA-based products and services, such as SistemQCTM, designed for the molecular characterisation of cells, combining robust miRNA profiling, statistical analysis and contextual analysis.
